Drug · DIN 02462400
BRINAVESS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 15, 2020; first marketed January 23, 2018.
- Drug Identification Number (DIN)
- 02462400
- Company (DIN owner)
- Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Vernakalant C01BG11
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VERNAKALANT HYDROCHLORIDE | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 24, 2018: NOC 21133New Drug Submission (NDS) · Merger - buyout
- March 13, 2017: NOC 19050New Drug Submission (NDS)